Tectonic Therapeutic, Inc. (TECX) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Tectonic is focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-Protein Coupled Receptors. We have developed a proprietary technology platform called GEODe™ to enable the discovery and development of GPCR-targeted biologic medicines that can modify the course of disease, by addressing challenges that have limited the pace of innovation in this field. Our focus is on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life.
the bull case· 3
124
managers reporting a position in thirteen f filings
13fJun 30 '26+0.33%
change in shares held by the ten largest reporting managers
13fJun 30 '2618
managers whose positions together make up four fifths of the reported value
13fJun 30 '26the bear case· 4
3
of the funds on file reporting a position in the company
n-portas of Jun 30 '260.01%
of ishares russell two thousand etf assets as the largest fund weight on file
n-portJun 30 '266 of 25
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '267 of 7
recent reports where the move came in under the options implied range
earnings historyimplied vs realizedSides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 12 '26 report. Not a forecast, not advice.
Of the 6 companies Tectonic Therapeutic, Inc. moves with most closely, none share its SEC classification.
Measured against 500 trading days of our own closes. Co-movement, not cause.
SIC 2836, Biological Products, (No Diagnostic Substances), from each company's own filings. Largest first.
tall tick = annual report · 1 on record
High 27.27 at 3:30 pm ET, low 26.66 at 11:15 am ET.
Tectonic Therapeutic, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
TECX (Tectonic Therapeutic, Inc.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
123 managers report a position worth $487.0M between them, and 18 of them hold 80% of it.